Skip to main content

Schaeffer Orlov S Nicole's Form 4 filing

INSMED Inc (INSM) · filed Jan 6, 2023

Accession no.
0001401017-23-000001
Filed
Jan 6, 2023
Trade date
Jan 5, 2023
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $28.6K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Schaeffer Orlov S NicoleCIK 0001401017Officer (Chief People Strategy Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 5, 2023Common StockSSaleDisposed−1,448$19.73−$28,569.0468,262Direct
Jan 5, 2023Common StockAGrant or awardAcquired+6,332–F4–74,594Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 5, 2023Common StockAGrant or awardAcquired+29,050$0.00$029,050Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F4

Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)